Citation: | LIANG Qi-fan, CUI Ji-wei, ZHANG Xin-ru, GUO Yu-miao, WANG Ruo-ning, DI Liu-qing. Preparation and in vitro Evalution of Glycyrrhizic Acid Self-Assembled Micelles Loading Tanshinone ⅡA[J]. Journal of Nanjing University of traditional Chinese Medicine, 2022, 38(6): 534-540. doi: 10.14148/j.issn.1672-0482.2022.0534 |
[1] |
李时珍. 本草纲目[M]. 北京: 中国书店, 1988: 21.
LI SZ. Compendium of Materia Medica[M]. Beijing: China Bookstore, 1988: 21.
|
[2] |
GAO S, LIU Z, LI H, et al. Cardiovascular actions and therapeutic potential of tanshinone ⅡA[J]. Atherosclerosis, 2012, 221(2): 604. doi: 10.1016/j.atherosclerosis.2012.01.014
|
[3] |
XIE J, LIU JH, LIU H, et al. The antitumor effect of tanshinone ⅡA on anti-proliferation and decreasing VEGF/VEGFR2 expression on the human non-small cell lung cancer A549 cell line[J]. Acta Pharm Sin B, 2015, 5(6): 554-563. doi: 10.1016/j.apsb.2015.07.008
|
[4] |
DONG WL, ZHANG YK, CHEN XM, et al. High-dose tanshinone ⅡA suppresses migration and proliferation while promoting apoptosis of astrocytoma cells via Notch-1 pathway[J]. Neurochem Res, 2018, 43(9): 1855-1861. doi: 10.1007/s11064-018-2601-0
|
[5] |
WANG J, WANG XJ, JIANG S, et al. Growth inhibition and induction of apoptosis and differentiation of tanshinone ⅡA in human glioma cells[J]. J Neuro Oncol, 2007, 82(1): 11-21. doi: 10.1007/s11060-006-9242-x
|
[6] |
KIM WS, KIM DO, YOON SJ, et al. Cryptotanshinone and tanshinone ⅡA enhance IL-15-induced natural killer cell differentiation[J]. Biochem Biophys Res Commun, 2012, 425(2): 340-347. doi: 10.1016/j.bbrc.2012.07.093
|
[7] |
ZHAO Q, LUAN X, ZHENG M, et al. Synergistic mechanisms of constituents in herbal extracts during intestinal absorption: Focus on natural occurring nanoparticles[J]. Pharmaceutics, 2020, 12(2): 128. doi: 10.3390/pharmaceutics12020128
|
[8] |
SELYUTINA OY, POLYAKOV NE. Glycyrrhizic acid as a multifunctional drug carrier-From physicochemical properties to biomedical applications: A modern insight on the ancient drug[J]. Int J Pharm, 2019, 559: 271-279. doi: 10.1016/j.ijpharm.2019.01.047
|
[9] |
LI S, ZHU JH, CAO LP, et al. Growth inhibitory in vitro effects of glycyrrhizic acid in U251 glioblastoma cell line[J]. Neurol Sci, 2014, 35(7): 1115-1120. doi: 10.1007/s10072-014-1661-4
|
[10] |
JUIN SK, GHOSH S, MAJUMDAR S. Glycyrrhizic acid facilitates anti-tumor immunity by attenuating Tregs and MDSCs: An immunotherapeutic approach[J]. Int Immunopharmacol, 2020, 88: 106932. doi: 10.1016/j.intimp.2020.106932
|
[11] |
WU WY, YAN H, WANG XB, et al. Sodium tanshinone ⅡA silate inhibits high glucose-induced vascular smooth muscle cell proliferation and migration through activation of AMP-activated protein kinase[J]. PLoS ONE, 2014, 9(4): e94957. doi: 10.1371/journal.pone.0094957
|
[12] |
ZHANG Y, WEI RX, ZHU XB, et al. Tanshinone ⅡA induces apoptosis and inhibits the proliferation, migration, and invasion of the osteosarcoma MG-63 cell line in vitro[J]. Anti Cancer Drugs, 2012, 23(2): 212-219. doi: 10.1097/CAD.0b013e32834e5592
|
[13] |
YUN SM, JUNG JH, JEONG SJ, et al. Tanshinone ⅡA induces autophagic cell death via activation of AMPK and ERK and inhibition of mTOR and p70 S6K in KBM-5 leukemia cells[J]. Phytother Res, 2014, 28(3): 458-464. doi: 10.1002/ptr.5015
|
[14] |
ZHANG KJ, LI J, MENG WT, et al. C/EBPβ and CHOP participate in Tanshinone ⅡA-induced differentiation and apoptosis of acute promyelocytic leukemia cells in vitro[J]. Int J Hematol, 2010, 92(4): 571-578. doi: 10.1007/s12185-010-0686-6
|
[15] |
CAI Y, ZHANG W, CHEN Z, et al. Recent insights into the biological activities and drug delivery systems of tanshinones[J]. Int J Nanomedicine, 2016, 11: 121-30. doi: 10.2217/nnm.15.185
|
[16] |
FAN LC, TENG HW, SHIAU CW, et al. SHP-1 is a target of regorafenib in colorectal cancer[J]. Oncotarget, 2014, 5(15): 6243-6251. doi: 10.18632/oncotarget.2191
|
[17] |
MA H, FAN Q, YU J, et al. Novel microemulsion of tanshinone ⅡA, isolated from Salvia miltiorrhiza bunge, exerts anticancer activity through inducing apoptosis in hepatoma cells[J]. Am J Chin Med, 2013, 41(1): 197-210. doi: 10.1142/S0192415X13500146
|
[18] |
LIU X, AN CY, JIN P, et al. Protective effects of cationic bovine serum albumin-conjugated PEGylated tanshinone ⅡA nanoparticles on cerebral ischemia[J]. Biomaterials, 2013, 34(3): 817-830. doi: 10.1016/j.biomaterials.2012.10.017
|
[19] |
ZHOU J, YU CH, PENG C. Anticancer effect of tanshinones on female breast cancer and gynecological cancer[J]. Front Pharmacol, 2022, 12: 824531. doi: 10.3389/fphar.2021.824531
|
[20] |
SUN J, XU ZS, HOU Y, et al. Hierarchically structured microcapsules for oral delivery of emodin and tanshinone ⅡA to treat renal fibrosis[J]. Int J Pharm, 2022, 616: 121490. doi: 10.1016/j.ijpharm.2022.121490
|
[21] |
ASHOUR AA, RAMADAN AA, ABDELMONSIF DA, et al. Enhanced oral bioavailability of Tanshinone ⅡA using lipid nanocapsules: Formulation, in-vitro appraisal and pharmacokinetics[J]. Int J Pharm, 2020, 586: 119598. doi: 10.1016/j.ijpharm.2020.119598
|